Your browser doesn't support javascript.
loading
Double pituitary neuroendocrine tumors in a patient with normal growth hormone level acromegaly: A case report and review of the literature.
Nakazato, Ichiro; Oyama, Kenichi; Ishikawa, Hisashi; Tabei, Yusuke; Inomoto, Chie; Osamura, Yoshiyuki; Teramoto, Akira; Matsuno, Akira.
Afiliação
  • Nakazato I; Department of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
  • Oyama K; Department of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
  • Ishikawa H; Department of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
  • Tabei Y; Department of Neurosurgery, International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan.
  • Inomoto C; Department of Pathology, Tokai University School of Medicine, Isehara, Japan.
  • Osamura Y; Division of Pathology, Nippon Koukan Hospital, Kanagawa, Japan.
  • Teramoto A; Faculty of Health Sciences, Shonan University of Medical Science, Kanagawa, Japan.
  • Matsuno A; Department of Neurosurgery, International University of Health and Welfare Narita Hospital, Narita, Japan.
Surg Neurol Int ; 14: 425, 2023.
Article em En | MEDLINE | ID: mdl-38213454
ABSTRACT

Background:

Acromegaly is a rare disease caused by growth hormone (GH) hypersecretion caused by a pituitary neuroendocrine tumor (PitNET). However, some acromegaly patients show normal GH levels, and they can be a pitfall in clinical diagnosis. Moreover, rarely, synchronous true double or multiple PitNETs are encountered. Moreover, these PitNETs increase the risk of a left lesion during surgical exploration. Case Description The patient, who was a 73-year-old female, was referred to our hospital with a chief complaint of headache. Assessment of basal anterior pituitary function revealed a slightly high level of insulin-like growth factor-1 (IGF-1) (standard deviation, 2.4), and her physical findings exhibited mild acromegalic features. The endocrine evaluation confirmed acromegaly and magnetic resonance imaging (MRI) showed a macro PitNET with suprasellar extension. Endoscopic endonasal surgery (EES) was performed to remove the macro PitNET. Although postoperative MRI showed complete removal of the macro PitNET, endocrinological testing indicated no improvement in GH or IGF-1 excess. Pathological examination of the surgical specimen revealed a gonadotropic PitNET. Therefore, we repeated the MRI scan and found a micro PitNET in the thin left normal pituitary gland. A second EES was successfully performed to remove the micro PitNET completely, and both endocrinological and pathological examinations confirmed that the disease was cured.

Conclusion:

Diagnosing acromegaly with low GH levels requires close monitoring. Double PitNETs are relatively rare and can cause incomplete remission of functional PitNETs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article